Beyond alphabeta/gammadelta lineage commitment: TCR signal strength regulates gammadelta T cell maturation and effector fate.
Signaling by the gammadelta T cell receptor (TCR) is required not only for alphabeta/gammadelta lineage commitment but also to activate and elicit effector functions in mature gammadelta T cells. Notably, at both of these stages, the signal delivered by the gammadeltaTCR is more robust than the one delivered by either the preTCR or the alphabetaTCR. Recent studies now provide evidence that signaling by the gammadeltaTCR is also required at other stages during gammadelta T cell development. Remarkably, the strength of the gammadeltaTCR signal also plays a role at these other stages, as evidenced by the findings that genetic manipulation of gammadeltaTCR signal strength affects gammadelta T cell maturation and effector fate. In this review, we discuss how a strong TCR signal is a recurring theme in gammadelta T cell development and activation.
Hayes
Sandra M
SM
Department of Microbiology & Immunology, SUNY Upstate Medical University, Syracuse, NY 13210, USA. hayessa@upstate.edu
Laird
Renee M
RM
Love
Paul E
PE
D000818:Animals; D002454:Cell Differentiation; D019070:Cell Lineage; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology* / Q000378:metabolism; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000276:immunology* / Q000378:metabolism; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000166:cytology* / Q000276:immunology* / Q000378:metabolism
D016693:Receptors, Antigen, T-Cell, alpha-beta; D016692:Receptors, Antigen, T-Cell, gamma-delta
Nat Rev Immunol. 2003 Mar;3(3):233-42
12658271
J Exp Med. 1998 Feb 2;187(3):357-65
9449716
J Immunol. 1988 Jun 15;140(12):4091-6
3259605
Immunity. 1998 Jun;8(6):713-21
9655485
Eur J Immunol. 1993 Jul;23(7):1655-60
8100777
Nat Immunol. 2003 Oct;4(10):991-8
14502287
J Exp Med. 2001 Mar 19;193(6):689-98
11257136
Immunity. 2005 May;22(5):595-606
15894277
Curr Opin Immunol. 1998 Apr;10(2):181-7
9602307
Immunity. 2009 Aug 21;31(2):321-30
19682928
Nature. 1995 Jun 29;375(6534):795-8
7596413
Semin Immunol. 1997 Jun;9(3):171-9
9200328
Eur J Immunol. 1998 Nov;28(11):3456-67
9842888
Immunity. 2009 Oct 16;31(4):565-75
19833086
Immunol Rev. 2003 Feb;191:28-37
12614349
Immunity. 2000 May;12(5):537-46
10843386
Adv Immunol. 1999;71:1-76
9917910
PLoS One. 2010 Jan 26;5(1):e8899
20126650
Immunity. 2009 Aug 21;31(2):331-41
19682929
J Immunol. 2010 Feb 1;184(3):1268-79
20038637
J Immunol. 1999 Sep 15;163(6):3076-82
10477572
Eur J Immunol. 1997 Feb;27(2):544-53
9045929
Immunol Rev. 1998 Oct;165:87-94
9850854
Eur J Immunol. 1992 Aug;22(8):2185-8
1386319
Nat Rev Immunol. 2002 May;2(5):336-45
12033739
Proc Natl Acad Sci U S A. 2009 May 19;106(20):8308-13
19416854
Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12453-8
19617548
Clin Immunol Immunopathol. 1998 Feb;86(2):121-33
9473374
Semin Immunol. 1999 Aug;11(4):239-49
10441210
Science. 2000 Oct 6;290(5489):127-31
11021796
Nat Immunol. 2006 Sep;7(9):995-1003
16878135
Immunity. 2002 Jun;16(6):827-38
12121664
J Immunol. 2006 Nov 1;177(9):6038-43
17056529
Int J Biochem Cell Biol. 2010 Mar;42(3):429-32
19647094
Blood. 2009 Jul 16;114(3):564-71
19443662
Curr Opin Immunol. 2006 Oct;18(5):527-33
16879956
Immunity. 2005 May;22(5):583-93
15894276
J Immunol. 2002 Jun 1;168(11):5699-708
12023369
Nat Immunol. 2003 Oct;4(10):999-1008
12970761
Annu Rev Immunol. 1995;13:93-126
7612239
Annu Rev Immunol. 1996;14:511-32
8717523
J Immunol. 2007 Oct 1;179(7):4635-44
17878361
Eur J Immunol. 2001 Jan;31(1):205-14
11265636
Science. 2007 Jan 12;315(5809):230-3
17218525
J Immunol. 2010 Feb 15;184(4):1675-9
20061408
Nat Immunol. 2009 Apr;10(4):427-36
19270712
Immunity. 2008 Jul 18;29(1):90-100
18585064
Annu Rev Immunol. 2000;18:975-1026
10837080
Annu Rev Immunol. 1999;17:829-74
10358775
Mol Cell Biol. 2006 Nov;26(22):8655-65
16966372
J Immunol. 2009 May 15;182(10):5904-8
19414740
Science. 2000 Jan 14;287(5451):314-6
10634788
J Exp Med. 2008 May 12;205(5):1173-86
18443226